1 of 31

DRUG INFORMATION CENTER NEWSLETTER

2 of 31

INDEX

    • drugs that can change urine (2)
    • treatment protocol for a patient with snakebite (3)
    • Can Glimipiride be used with Ketoprofen? (4)
    • Can Glimipiride be used with Lisinopril? (4)
    • Crohn’s disease (5)
    • METHOTREXATE & AMOXICILLIN (6)
    • ANTIVENOM & SNAKEBITES (6)
    • VITAMINS (7)
    • VITAMIN D & AZITHROMYCIN (7)
    • ALENDRONATE & CIPROFLOXACIN (8)
    • theophylline & CIPROFLOXACIN (9)
    • vitamin k and warfarin (10)
    • digoxin and newborn (11)
    • MEBENDAZOLE & METRONIDAZOLE (12)
    • ASPIRIN WITH ASTHMA PATIENTS (12)
    • beta blockers & DIABETES MEDICATIONS (13)
    • SIDE EFFECTS OF CAPTOPRIL (13)
    • drug - drug interactions of capecitabine (14)
    • drug - disease interaction of capecitabine (14)
    • Diuretics & gouty patient (15)
    • Gastroparesis (15)
    • Aspirin & infant has viral infection (16)
    • Metformin & chronic kidney disease (16)
    • Simvastatin and clarithromycin (17)
    • Alcohol and NSAIDs (17)
    • Omeprazole & CLARITHROMYCIN (18)
    • Omeprazole & Clopidogrel (19)
    • Loperamide (20)
    • Epinephrine and nose bleeding (21)
    • warfarin and sulfadiazine (22)
    • Neurontin and Endari with sickle cell anemia and seizures (23)
    • colchicine and amoxicillin (24)
    • Colchicine and Clarithromycin (25)
    • contraindications for using Ivabradine (26)
    • PREGNANCE (27-30)

page 1

3 of 31

DRUGS THAT CAN CHANGE URINE

Several drugs can cause urine discoloration due to the way they are metabolized or excreted. Here's a list categorized by the color they may produce

WHAT ARE THE DRUGS THAT CAN CHANGE URINE COLOR?

1-Red or Pink Urine

Phenazopyridine – urinary tract analgesic.

2-Orange Urine

Sulfasalazine – anti-inflammatory drug.

3-Brown or Dark Brown Urine

Methyldopa – antihypertensive.

4-Blue or Green Urine

Cimetidine – H2-blocker.

5-Purple Urine (rare, usually in catheters)

Not typically from drugs; more often due to Purple Urine Bag Syndrome, involving bacteria and tryptophan metabolism.

page 2

4 of 31

treatment protocol for a patient with snakebite

1. Reassure the patient and keep them calm to slow venom spread.

2. Immobilize the affected limb with a splint; keep it below heart level.

3. Remove tight clothing or jewelry near the bite area.

4. Do not apply tourniquets, cut the wound, suck the venom, or apply ice.

Initial First Aid:

Hospital Management:

1. Assess the patient clinically for signs of envenomation:

o Local signs: swelling, bruising, necrosis.

o Systemic signs: hypotension, coagulopathy, neurotoxicity (e.g., ptosis,

difficulty breathing), renal impairment.

2. Monitor vital signs and perform laboratory tests: coagulation profile, renal

function, electrolytes, and complete blood count.

Antivenom Administration:  Indications:

o Progressive local swelling crossing a joint or involving more than half a limb.

o Systemic signs: bleeding, coagulopathy, neurotoxicity, hypotension, shock, or

acute kidney injury..

page 3

5 of 31

GLIMEPIRIDE

&

KETOPROFEN

Using glimepiride (a sulfonylurea antidiabetic) together with ketoprofen (a nonsteroidal

anti-inflammatory drug, NSAID) is possible, but with caution due to potential interactions.

Interaction Risk:

Increased risk of hypoglycemia: NSAIDs like ketoprofen can enhance the glucose-lowering

effect of sulfonylureas like glimepiride by:

Reducing renal clearance.

Recommendations:

Can be used together if:

The ketoprofen dose is limited and short-term.

Blood glucose is monitored closely.

Avoid in:

Elderly or frail patients with poor hypoglycemia awareness.

Chronic NSAID use without appropriate monitoring. .

Safer Alternatives:

If pain relief is needed and hypoglycemia risk is a concern, consider:

  • Paracetamol (acetaminophen) as a first-line alternative.
  • Topical NSAIDs to reduce systemic exposure.

Glimipiride &

Lisinopril

Yes, glimepiride and lisinopril can be used together, but with close monitoring, as they may

have a synergistic effect on blood glucose, potentially increasing the risk of hypoglycemia .

  • Interaction Details:

Together, they may cause additive glucose-lowering effects, leading to hypoglycemia,

especially in the early weeks of co-therapy or dose adjustment

Clinical Guidelines and Recommendations:

Common combination in diabetic hypertensive patients; often beneficial due to:

o Cardiovascular and renal protective effects of ACE inhibitors.

o Metabolic benefits.

 Monitor blood glucose levels, particularly:

o When starting or increasing the dose of lisinopril.

o In patients with renal impairment (lisinopril is renally excreted).

Educate patients about signs of hypoglycemia (e.g., sweating, tremor,

confusion, palpitations).

page 4

6 of 31

treatment of Crohn’s disease

  1. Medical Therapy:

Induction and Maintenance of Remission:

Aminosalicylates (5-ASA): e.g., mesalamine (limited role in Crohn’s)

Corticosteroids: e.g., prednisone, budesonide (for flares, not for long-term use)

Immunomodulators:

  1. Azathioprine
  2. 6-Mercaptopurine
  3. Methotrexate

2- Nutritional Support:

High-calorie, nutrient-dense diets Nutritional supplements (especially iron, B12, folate, vitamin D)

Elemental diets in pediatric patients .

3. Surgery:

Required in up to 70% of patients at some point due to:

o Obstruction

o Abscess

o Fistula

o Failure of medical therapy

Note: surgery is not curative—disease often recurs at the site of resection..

4. Monitoring and Support:

Regular colonoscopy and imaging (e.g., MRI enterography)

Vaccinations and bone health monitoring

Psychological support and counseling

symptoms of Crohn’s disease

Crohn’s disease is a chronic, relapsing inflammatory bowel disease (IBD) that can affect

any part of the gastrointestinal tract—most commonly the terminal ileum and colon. It

involves transmural inflammation, which can lead to complications like strictures, fistulas,

and abscesses.

  • Symptoms of Crohn’s Disease:

a) General:

  1. Chronic diarrhea (may be bloody)
  2. Abdominal pain and cramping (often in the lower right quadrant)
  3. Weight loss and malnutrition
  4. Fatigue
  5. Fever
  6. Reduced appetite

b) Extraintestinal Symptoms:

Joint pain (arthritis)

Skin disorders (e.g., erythema nodosum, pyoderma gangrenosum)

Eye inflammation (e.g., uveitis, episcleritis)

Mouth ulcers

Liver inflammation (e.g., primary sclerosing cholangitis)

page 5

7 of 31

Not necessary in every case:

  • Dry bites (no venom injected) and bites from non-venomous snakes do not require antivenom.

  • Mild local reactions without systemic involvement may be managed symptomatically.

METHOTREXATE & AMOXICILLIN

  • there is a clinically significant interaction between methotrexate and amoxicillin, and it requires caution.

  • This may lead to increased methotrexate blood levels, potentially resulting in toxicity (e.g., bone marrow suppression, hepatotoxicity, or mucositis).

Clinical Recommendations:

  • Avoid combination if possible, especially in high-dose methotrexate therapy

ANTIVENOM & SNAKEBITES

page 6

8 of 31

  • you can safely take Vitamin D while using Azithromycin. There is no known significant interaction between the two. There is no need to adjust dosage or timing of either medication

Things to Keep in Mind:

  • If you’re taking other medications or have heart/kidney issues, always consult your doctor before combining supplements or antibiotics.

VITAMINS

  • Vitamins aren’t a shortcut to weight loss, but they can support health during a calorie-restricted or physically active lifestyle.

Why You Might Need Vitamins During Weight Loss:

  • Calorie restriction: If you’re eating fewer calories, you might unintentionally miss out on essential nutrients (e.g., vitamin D, B12, iron, or magnesium).
  • Eliminating food groups: Diets that restrict certain groups (e.g., dairy, meat, or grains) may create deficiencies.
  • Increased activity: Exercise increases demand for certain vitamins and minerals (like B vitamins, magnesium, and antioxidants).

VITAMIN D &

AZITHROMYCIN

page 7

9 of 31

there is a moderate interaction between alendronate and ciprofloxacin, primarily related to absorption issues and gastrointestinal (GI) side effects.

Interaction Details:

  • Reduced Absorption:
  • Both alendronate and ciprofloxacin require proper timing for absorption.
  • Taking them together or too closely may decrease the absorption of ciprofloxacin, making it less effective.

  • Gastrointestinal Risk:
  • ·Both drugs can cause GI irritation (e.g., esophagitis, gastritis).
  • ·Taking them together may increase the risk of GI adverse effects, especially in sensitive individuals.

ALENDRONATE & CIPROFLOXACIN

Clinical Recommendations:

  • Administer alendronate first, following strict guidelines:
  • Take first thing in the morning on an empty stomach.
  • Swallow with a full glass of water.
  • Wait at least 30–60 minutes before eating, drinking, or taking other medications (including ciprofloxacin).

  • Administer ciprofloxacin later, ideally at least 2 hours after alendronate

page 8

10 of 31

Ciprofloxacin interacts significantly with theophylline, and this interaction can lead to

serious clinical consequences if not managed properly. .

Mechanism:

Ciprofloxacin inhibits cytochrome P450 1A2 (CYP1A2), which is the primary

enzyme responsible for metabolizing theophylline.

As a result, theophylline levels increase in the blood.

In severe cases, life-threatening toxicity can occur, especially in elderly patients or those

with comorbidities.

Clinical Implications:

Increased theophylline levels can cause toxicity, including:

 Nausea and vomiting

 Insomnia

 Tremors

 Seizures

 Cardiac arrhythmias

 Restlessness or anxiety

theophylline & CIPROFLOXACIN

Recommendations:

1. Avoid concurrent use if possible

2. If used together:

Take first thing in the morning on an empty stomach.

Monitor serum theophylline levels closely. Consider reducing the theophylline dose. Watch for signs and symptoms of theophylline toxicity.

3. Consider alternative antibiotics (e.g., levofloxacin, which has a lower impact on

CYP1A2).

page 9

11 of 31

There is a well-known and significant interaction between vitamin K and warfarin

because vitamin K directly opposes the effect of warfarin, which can impact blood clotting

control. .

Warfarin Mechanism:

Warfarin works by inhibiting vitamin K epoxide reductase, an enzyme required to activate vitamin K–dependent clotting factors (II, VII, IX, X).

This reduces blood clotting to prevent thromboembolic events (e.g., strokes, DVTs).

Vitamin K's Role:

Vitamin K reverses the effect of warfarin by restoring clotting factor activation,

making the blood more likely to clot.

High or inconsistent intake of vitamin K can lower the INR (International Normalized Ratio),

reducing warfarin’s effectiveness

vitamin k and warfarin

Clinical Recommendations:

Keep dietary vitamin K intake consistent (avoid sudden increases or decreases).

If vitamin K supplements are used (e.g., for reversal of warfarin), it should be under strict medical supervision.

Monitor INR regularly to adjust warfarin dosing accordingly.

page 10

12 of 31

Digoxin can be used in newborns with ventricular septal defect (VSD), but its use depends

on the clinical condition of the baby.

Indications for Digoxin in VSD:

 VSDs, especially moderate to large, can cause heart failure symptoms due to

increased pulmonary blood flow and volume overload.

 Digoxin may be prescribed if the infant shows signs of congestive heart failure

(CHF) such as:

o Poor feeding

o Failure to thrive

o Tachypnea or respiratory distress

o Hepatomegaly

Benefits of Digoxin in This Setting:

 Improves myocardial contractility (positive inotrope)

 Helps control heart rate (especially in cases with atrial arrhythmias)

 May help reduce symptoms of heart failure while waiting for spontaneous

closure or surgical intervention

digoxin and newborn

Important Considerations:

 Not needed in asymptomatic newborns with small VSDs.

 Requires careful dosing and monitoring due to the narrow therapeutic window,

especially in neonates.

 Contraindicated in patients with certain arrhythmias or significant renal impairment

without proper dose adjustment..

page 11

13 of 31

MEBENDAZOLE &

METRONIDAZOLE

Interaction Overview:

    • Concomitant use of Mebendazole and Metronidazole has been associated with Stevens-Johnson Syndrome (SJS) and toxic epidermal necrolysis (TEN), which are severe, potentially life-threatening skin reactions.

Clinical Recommendations:

    • Avoid combining mebendazole and metronidazole unless absolutely necessary.
    • If co-administration is considered, monitor very closely for early signs of:
      • Rash or blistering
      • Fever
      • Mucosal involvement (e.g., oral ulcers)
    • there is a potentially serious interaction between Mebendazole and Metronidazolethough rare, it is clinically significant.

ASPIRIN WITH ASTHMA PATIENTS

    • aspirin can cause problems in some asthma patients—a condition known as aspirin-exacerbated respiratory disease (AERD), or aspirin-sensitive asthma

Aspirin sensitivity affects about 5–20% of adults with asthma, especially if they also have:

    • Nasal polyps
    • Chronic rhino sinusitis
    • ·History of bronchospasm or wheezing after taking NSAIDs

Recommendations:

    • Avoid aspirin in asthma patients with a known or suspected sensitivity.
    • If pain relief is needed:
      • Use acetaminophen (paracetamol) as a safer alternative (though still with caution).
      • Some patients may tolerate COX-2 inhibitors (like celecoxib), but only under medical supervision.

page 12

14 of 31

beta bLOCKERS &

DIABETES MEDICATIONS

  • Beta blockers and diabetes medications can interact in ways that affect blood glucose levels and mask symptoms of hypoglycemia, making their combined use clinically significant, especially in patients with insulin-dependent diabetes.

Clinical Implications:

  • Cardioselective beta blockers (e.g., metoprolol, atenolol) are safer options in diabetics as they are less likely to blunt hypoglycemia signs.

    • Close blood glucose monitoring is essential when:
      • Starting or adjusting beta blockers.
      • Combining with insulin or insulin secretagogues.

    • Educate patients to recognize non-adrenergic hypoglycemia symptoms (confusion, hunger, vision changes).

SIDE EFFECTS OF CAPTOPRIL

Captopril, an ACE inhibitor used to treat high blood pressure and heart failure, has several potential side effects ranging from mild to serious. Here’s a detailed breakdown:

Common Side Effects:

  • Dry, persistent cough – One of the hallmark side effects of ACE inhibitors like captopril, caused by bradykinin accumulation.
  • Dizziness or lightheadedness – Often occurs after the first few doses, especially in people who are dehydrated or also on diuretics.

Serious Side Effects:

  • Low blood pressure (hypotension) – Can occur suddenly, particularly after the first dose or in volume-depleted individuals.
  • Elevated potassium levels (hyperkalemia) – Can lead to muscle weakness, irregular heartbeat, or more serious cardiac complications.

Monitoring Recommendations:

  • Healthcare providers typically monitor blood pressure, kidney function (serum creatinine), potassium levels, and in some cases, white blood cell counts during captopril therapy.

page 13

15 of 31

drug - drug interactions of capecitabine

Capecitabine is an oral prodrug of 5-fluorouracil (5-FU), used to treat several cancers

including breast, colorectal, and gastric cancers. It has significant drug–drug interactions

that require careful monitoring..

1. Warfarin (and other anticoagulants):

Interaction: Increased anticoagulant effect → risk of serious bleeding .

Action: Monitor INR closely and adjust warfarin dose as needed.

2. Phenytoin

Interaction: Increased phenytoin levels → risk of toxicity (e.g., ataxia, confusion)Starting or adjusting beta blockers.

Action: Monitor serum phenytoin levels; adjust dose if necessary.

3. Leucovorin (folinic acid) Interaction: Enhances capecitabine’s effects (and toxicity)

Action: Avoid co-administration unless part of a protocol; monitor

closely

4. Allopurinol

Interaction: May reduce efficacy of capecitabine.

Action: Use alternative agents if possible.

drug - disease interaction of capecitabine

  1. Renal Impairment

Capecitabine is renally excreted; impaired function leads to increased toxicity

(diarrhea, mucositis, neutropenia).

Action: Dose adjustment required in moderate renal impairment; contraindicated

in severe renal impairment (CrCl < 30 mL/min).

2. Hepatic Dysfunction

  • May increase toxicity due to impaired drug metabolism.
  • Use with caution; monitor liver function tests.

3. coronary artery disease (CAD) Low blood pressure (Capecitabine can cause coronary vasospasm, leading to chest pain or MI.

Caution in patients with cardiac history.otassium levels (hyperkalemia) – Can lead to muscle weakness, irregular heartbeat, or more serious cardiac complications.

Dihydropyrimidine Dehydrogenase (DPD) Deficiency :

Contraindicated: DPD deficiency leads to severe, potentially fatal toxicity (neutropenia, mucositis, diarrhea).

page 14

16 of 31

diuretics&

gouty patient

Diuretics are not strictly contraindicated in patients with gout, but they are used with

caution because they can increase the risk of gout flares or worsen hyperuricemia.

Management Strategies:

Avoid or minimize use of these diuretics in patients with active or frequent gout if possible. .

Consider alternative antihypertensives that are more gout-friendly, such as:

  1. Losartan (an angiotensin receptor blocker that can lower uric acid)
  2. Calcium channel blockers (e.g., amlodipine) .

If diuretics are needed for conditions like heart failure or hypertension, the benefit

may outweigh the risk — in such cases:

  1. Treat hyperuricemia concurrently with xanthine oxidase inhibitors (e.g.,

allopurinol or febuxostat).

  1. Monitor serum uric acid levels and adjust gout therapy as needed.

gastroparesis

Gastroparesis is a condition where the stomach empties food into the small intestine more

slowly than normal, without a physical blockage. Symptoms can range from mild to severe

and often resemble other gastrointestinal conditions.

Common Symptoms of Gastroparesis:

1. Nausea

2. Vomiting (especially of undigested food hours after eating)

3. Early satiety (feeling full quickly after starting a meal)

4. Bloating

5. Abdominal pain or discomfort

6. Loss of appetite

7. Weight loss (due to reduced food intake or vomiting)

8. Heartburn or acid reflux

9. Fluctuating blood glucose levels (especially in diabetics)

10. Malnutrition or dehydration in severe casesMonitoring

  • Associated Conditions:

Diabetes mellitus (most common cause)

Post-surgical complications (e.g., vagus nerve damage) Medications (e.g., opioids, anticholinergics)

diopathic (no clear cause in many cases).

page 15

17 of 31

aspirin&

infant has viral infection

No, aspirin is not safe for infants or children with a viral infection.

Why? Risk of Reye's Syndrome

It has been strongly linked to aspirin use during viral infections, particularly in

children under 16 years old.

Reye’s syndrome is a rare but potentially fatal condition that can cause:

o Acute liver failure

o Encephalopathy (brain swelling)

Common Viruses That Raise Risk with Aspirin:

 Influenza (flu)

 Varicella (chickenpox)

 Other nonspecific viral illnesses (e.g., upper respiratory infections)

Safe Alternatives for Fever or Pain in Infants:

 Acetaminophen (paracetamol): safe for infants over 2 months (adjust dose by

weight)

 Ibuprofen: safe for infants over 6 months (avoid in dehydration or kidney issues)

metformin& chronic kidney disease

Metformin is contraindicated or used with caution in chronic kidney disease (CKD)

because of the risk of lactic acidosis, a rare but potentially fatal metabolic complication. Why It's a Concern:

1. Renal Clearance of Metformin

Metformin is excreted unchanged by the kidneys.

In CKD, reduced kidney function leads to accumulation of metformin, increasing

the risk of lactic acidosis.

2. Lactic Acidosis Risk

Metformin can increase lactate production by inhibiting hepatic gluconeogenesis.

When kidneys can't clear lactate or metformin properly, serum lactate levels rise,

leading to:

Acidosis

Weakness, confusion, respiratory distress

High mortality if not promptly treated

page 16

18 of 31

Simvastatin and clarithromycin

Yes, there is a serious interaction between simvastatin and clarithromycin. This

combination should generally be avoided due to a high risk of severe muscle toxicity,

including rhabdomyolysis. .

Mechanism:

Clarithromycin is a strong CYP3A4 inhibitor.

Simvastatin is primarily metabolized by CYP3A4.

Co-administration results in markedly increased simvastatin levels in the blood.

Clinical Implications:

 Increased risk of:

Myopathy (muscle pain or weakness with elevated CK)

Rhabdomyolysis (severe muscle breakdown → kidney damage)

 Risk is dose-dependent, higher with simvastatin doses >20 mg.

Recommendations:

 Avoid coadministration of simvastatin and clarithromycin.

 Alternatives:

o Use a different antibiotic (e.g., azithromycin or doxycycline) if continuing

simvastatin.

o If clarithromycin must be used, temporarily stop simvastatin during

antibiotic treatment and resume 3–5 days after.

Alcohol and NSAIDs

Alcohol and NSAIDs (nonsteroidal anti-inflammatory drugs) can interact in a way that

increases the risk of serious gastrointestinal and renal side effects, among others.

Key Interactions between Alcohol and NSAIDs:

  1. Gastrointestinal (GI) Toxicity

 Both alcohol and NSAIDs irritate the stomach lining.

 Combined use increases the risk of:

o Gastritis

o GI bleeding

o Peptic ulcers

 Risk is dose-dependent and higher with chronic alcohol use or high NSAID doses.

2. Renal (Kidney) Impairment

 Combined use increases the risk of:

o Acute kidney injury (AKI)

o Fluid retention and elevated blood pressure

3. Liver Damage

 Chronic use of both may contribute to liver enzyme elevation or damage.

4. Bleeding Risk

Together, they increase bleeding risk, particularly in:

o GI tract

o Postoperative or injury settings

Clinical Advice:

Avoid regular or high-dose NSAID use with frequent alcohol consumption.

page 17

19 of 31

Omeprazole &

Clarithromycin

there is a clinically significant interaction between omeprazole and clarithromycin, but it is often intentionally used in therapy, particularly for Helicobacter pylori eradication.

Used Together in Clinical Practice:

  • Omeprazole + Clarithromycin + Amoxicillin is a standard triple therapy for H. pylori eradication.
  • The interaction is beneficial in this context and monitored clinically.

Recommendations:

  • Safe to use together when clinically indicated.
  • Monitor for cardiac risk factors, especially in older adults or those on multiple medications.
  • Watch for side effects like GI upset, taste disturbances, or cardiac symptoms if prolonged use occurs.

page 18

20 of 31

Omeprazole & Clopidogrel

there is a clinically significant interaction between omeprazole and clopidogrel, which may reduce the effectiveness of clopidogrel and increase the risk of cardiovascular

events such as heart attack or stroke.

Interaction Mechanism:

When taken together, omeprazole reduces the conversion of clopidogrel into its active

form, leading to decreased antiplatelet effect .

Recommendations:

1. Avoid omeprazole in patients taking clopidogrel when possible.

2. If a proton pump inhibitor (PPI) is needed for GI protection:

Prefer pantoprazole or esomeprazole (less CYP2C19 inhibition than omeprazole).

Or consider H2-blockers like famotidine (except cimetidine).

page 19

21 of 31

loperamide is contraindicated in children under 6 years of age, including 5-year-old

children, especially when used to treat acute diarrhea.

Reasons for Contraindication

1-Reduced Absorption:

May prolong infection

Loperamide slows gut movement, which can delay clearance of infectious agents in

diarrhea caused by viruses or bacteria..

2-FDA and WHO guidelines:

The U.S. FDA, WHO, and American Academy of Pediatrics recommend against

the use of loperamide in children under 6 years.

loperamide

Safer alternatives

Oral Rehydration Solution (ORS) to prevent dehydration.

Zinc supplementation (recommended by WHO for 10–14 days).

Continue regular feeding (avoid restrictive diets unless medically advised). .

Seek medical evaluation if diarrhea is severe, bloody, persistent, or associated with

high fever.

page 20

22 of 31

Epinephrine can be considered as a treatment option for nosebleeds (epistaxis) in specific clinical settings, but it is not first-line for most routine cases.

When Epinephrine May Be Used for Nosebleeds:

  1. As a Topical Vasoconstrictor:

Indication: When simple pressure, cautery (silver nitrate), or nasal packing fails to

control bleeding.

2. During Nasal Endoscopy or ENT Procedures

ENT specialists may use epinephrine in combination with lidocaine (as a

vasoconstrictor and anesthetic) during nasal cauterization or surgical control of

epistaxis.

3. In Emergency or Massive Bleeding Cases

For posterior epistaxis or when bleeding is hemodynamically significant, topical

epinephrine can be part of a multimodal approach (alongside nasal packing, cautery,

and possibly surgical intervention).

Cautions and Contraindications:

Use with caution in patients with:

Hypertension

Cardiovascular disease

Arrhythmias

Risk of systemic absorption, leading to elevated heart rate, blood pressure, and

possible cardiac effects.

Epinephrine and nose bleeding

Not Used:

As a systemic injection for epistaxis.

As monotherapy for recurrent or structural causes of nosebleeds.

Page 21

23 of 31

Yes, there is a significant interaction between warfarin and sulfadiazine that requires

careful monitoring.

1. Increased Risk of Bleeding

Sulfadiazine (a sulfonamide antibiotic) can potentiate the effects of warfarin,

leading to an increased INR (International Normalized Ratio) and higher bleeding

risk.

2. Clinical Consequences:

Increased risk of bleeding complications such as bruising, nosebleeds,

gastrointestinal bleeding, or more serious hemorrhage

warfarin and sulfadiazine

Recommendations:

Avoid if possible, especially for long-term use.

If co-administration is necessary:

Monitor INR closely (frequently during initiation and dose changes).

Consider warfarin dose adjustment based on INR response.

Educate the patient to report any signs of bleeding.

page 22

24 of 31

a patient with sickle cell anemia and seizures can generally take both Neurontin

(gabapentin) and Endari (L-glutamine), but some precautions are necessary.

    • Neurontin (Gabapentin):

Use: Commonly prescribed for seizure control and neuropathic pain, which some

sickle cell patients may experience.

Safety in Sickle Cell: Generally safe and well-tolerated.

2. Endari (L-glutamine oral powder):

Use: Approved by the FDA to reduce acute complications of sickle cell disease,

such as vaso-occlusive crises.

Safety in Seizure Disorders:

o Not known to lower seizure threshold.

o Clinical trials did not show an increase in seizure risk, even in patients taking

anticonvulsants.

Neurontin and

Endari with sickle cell anemia and seizures

Clinical Recommendation:

This combination can be used together under supervision.

Ensure renal function is monitored.

Review full medication list to check for other interacting drugs or seizure triggers

page 23

25 of 31

There is no direct or clinically significant interaction between colchicine and amoxicillin

in most patients. However, certain cautions apply depending on the patient's condition Key Considerations:

1. Renal Impairment:

Both drugs are eliminated via the kidneys.

In patients with kidney dysfunction, the risk of colchicine toxicity

increases, especially if other drugs affecting clearance are used.

Amoxicillin can, in rare cases, cause interstitial nephritis, which could

impair renal function and indirectly affect colchicine levels.

2. Overlap of Side Effects:

Approved Both drugs can cause GI side effects (nausea, vomiting, diarrhea).

Taking them together may worsen GI discomfort.

colchicine and amoxicillin

Safe Use Recommendation:

Generally safe to use together in patients with normal renal and hepatic function.

Monitor renal function in older adults or those with preexisting kidney disease.

Watch for colchicine toxicity signs: muscle pain, weakness, severe diarrhea, or

numbness

page 24

26 of 31

The interaction between colchicine and clarithromycin is severe and potentially life-threatening.

They should not be used together unless absolutely necessary and under close medical supervision.

Interaction Severity: Major (Contraindicated or avoid if possible)

Mechanism of Interaction:

Clarithromycin is a strong inhibitor of CYP3A4 and P-glycoprotein (P-gp). Colchicine is metabolized and cleared by CYP3A4 and P-gp.

Co-administration leads to toxic accumulation of colchicine

Safer Alternatives to Clarithromycin:

Azithromycin (less CYP3A4 inhibition)

Doxycycline (if appropriate for infection)

Cephalosporins or penicillins (depending on the infection type)

Colchicine and Clarithromycin

Severe colchicine toxicity may include:

Myelosuppression (bone marrow failure) Rhabdomyolysis (muscle breakdown)

Multi-organ failure

Death, especially in elderly or renally impaired patients

page 25

27 of 31

Ivabradine is a heart rate–lowering medication primarily used to treat chronic heart failure

and inappropriate sinus tachycardia. While it can be effective, there are several important

contraindications to its use.

Absolute Contraindications to Ivabradine:

1. Resting heart rate below 70 bpm (in patients with heart failure)

2. Acute decompensated heart failure

3. Sick sinus syndrome, sinoatrial block, or 3rd-degree AV block (unless a

functioning pacemaker is in place)

4. Pacemaker-dependent patients

5. Severe hepatic impairment

6. Bradycardia (significant baseline bradycardia)

7. Blood pressure <90/50 mmHg

8. Hypersensitivity to ivabradine or its components

9. Concomitant use of strong CYP3A4 inhibitors, such as:

o Ketoconazole

o Itraconazole

o Clarithromycin

o Nefazodone

o Ritonavir

contraindications for using Ivabradine

Relative Contraindications / Use with Caution:

Atrial fibrillation or other arrhythmias not controlled by medication

Unstable angina

Pregnancy and breastfeeding (not recommended unless essential)

Visual disturbances (can worsen with ivabradine)

page 26

28 of 31

PREGNANCE

    • Penicillins (e.g., amoxicillin, ampicillin)
    • b) Cephalosporins (e.g., cephalexin, cefuroxime, ceftriaxone)
    • Macrolides (e.g., azithromycin, erythromycin not the estolate form)
    • Clindamycin
    • Nitrofurantoin
    • Fosfomycin
    • Metronidazole

THE BEST SAFE ANTIBIOTICS FOR PREGNANT WOMEN AND DURING BREASTFEEDING

page 27

29 of 31

pregnance

Antibiotics to Avoid during Pregnancy

Safest Pain and Fever drugs used in pregnant women in the first trimester

    • Tetracyclines

(e.g., doxycycline): Can affect bone growth and stain fetal teeth.

    • Fluoroquinolones

(e.g., ciprofloxacin, levofloxacin): Concerns about effects on cartilage development.

    • Trimethoprim-sulfamethoxazole (TMP-SMX)

Risks include neural tube defects (early pregnancy) and kernicterus (late pregnancy).

    • Aminoglycosides

(e.g., gentamicin): Risk of ototoxicity (hearing damage), especially with prolonged use.

    • Chloramphenicol

Risk of “gray baby syndrome

Paracetamol (acetaminophen): First-line for pain or fever; considered safe.

    • Avoid prolonged or high-dose use.
    • NSAIDs (like ibuprofen) should be avoided, especially in later pregnancy.

Safest Antifungals (topical) used in pregnant women in the first trimester

    • ·Clotrimazole, miconazole: Safe for vaginal yeast infections.
    • ·Avoid oral fluconazole during the first trimester due to potential birth defect risk.

page 28

30 of 31

pregnance

Safest Antiemetic used in pregnant women in the first trimester

    • Pyridoxine (vitamin B6) and doxylamine: First-line treatment.
    • Ginger supplements (limited but positive safety data).
    • Metoclopramide and ondansetron: Used if symptoms are severe; ondansetron use in early pregnancy remains controversial—use only if benefits outweigh risks.

Safest Antacids used in pregnant women in the first trimester

    • Antacids (e.g., calcium carbonate): Safe for occasional heartburn.
    • Ranitidine and famotidine (H2 blockers): Generally considered safe.
    • ·Omeprazole (proton pump inhibitor): Use only if H2 blockers fail; data suggests safety but use cautiously in first trimester.

Safest Allergy drugs used in pregnant women in the first trimester

    • Loratadine and cetirizine: Second-generation antihistamines considered safe.
    • Chlorpheniramine: First-generation option with good safety record.

Safest Constipation & Diarrhea drugs used in pregnant women in the first trimester

    • Bulk-forming laxatives (psyllium, methylcellulose): Safe and first-line.
    • Docusate sodium: Acceptable stool softener.
    • Loperamide: Use cautiously if necessary; short-term use acceptable

page 29

31 of 31

AMOXICILLIN WITH pregnance

Classification and Safety:

    • FDA Pregnancy Category B (older system):

Animal studies have not shown harm to the fetus, and there are no well-controlled human studies showing risk.

    • Current clinical consensus:

Amoxicillin is widely used in pregnant women for infections such as urinary tract infections, sinusitis, and respiratory infections without evidence of harm.

Safe Use:

    • Commonly prescribed during all trimesters.
    • Does not increase risk of congenital malformations when used appropriately.
    • Crosses the placenta, but is not associated with harmful fetal effects.

Precautions:

    • Use only under medical supervision.
    • Watch for allergic reactions (especially if the woman has a penicillin allergy).
    • Ensure correct diagnosis and dose self-medicating during pregnancy is never advised.

Safest Prenatal Supplements used in pregnant women in the first trimester

    • Folic acid (400–800 mcg/day): Essential to prevent neural tube defects.
    • Iron: Used if iron-deficiency anemia is present.
    • ·Calcium and vitamin D: Support bone development and maternal needs.

page 30